HEMEL HEMPSTEAD, United Kingdom – 9 September, 2024 – A new survey highlights the profound impact chronic pain has on the lives of people living in the UK, often severely affecting their mental health and well-being. Young respondents (aged 16 to 24), part of the Gen Z demographic, appear to be impacted the most, scoring higher in all categories than older age groups, with 73% reporting experiencing social isolation at least once a week due to their chronic pain. Almost one in three of those Gen Z respondents (29%) state that due to their pain they ‘feel like they can’t go on.’ The survey was commissioned by Boston Scientific in July 2024 and canvassed 1,000 respondents in the UK.
Chronic pain, defined as pain that lasts more than 12 weeks1, is estimated to affect between one-third to one-half of the population of UK adults (up to 28 million people).2 The research uncovered how the condition affects almost every aspect of life, including sleep, exercise, relationships and work, undermining mental health.
-
Sleep and exercise: More than seven in 10 respondents reported disruption to sleep (71%) and exercise (72%), at least once a week — both of which are critical for good mental health.3
-
Anxiety and depression: Among all UK respondents, 61% and 53% reported experiencing anxiety and depression, respectively, at least once a week. The impact was the highest among the Gen Z demographic, with the majority of those experiencing these negative feelings at least weekly reaching 80% for anxiety and 71% for depression.
-
Caregiver network: One in five respondents feel that their friends (17%), family (22%), and even doctors (22%) understand how chronic pain affects their mental state.
“Chronic pain is misunderstood, underdiagnosed and undertreated, yet these results show just how much it can dominate every aspect of life and severely impact mental health, especially in younger adults,” says Dr Ashish Gulve, consultant in Pain Medicine from the James Cook University Hospital, Middlesbrough. “With numerous treatment options now available, no one should have to endure chronic pain in silence. I would urge anyone who has been living with the condition for more than 12 weeks to talk openly to their health care professional.”
The survey also highlights the need for better awareness and less stigma around chronic pain, as only six percent of survey participants feel comfortable initiating conversations about their condition.
“The responses uncover the true toll chronic pain takes on the mental and emotional health of those affected. Chronic pain needs to be viewed holistically and as a health issue that needs to be discussed more openly,” said Vincent Sourdaine, vice president, Neuromodulation in Europe, Middle East and Africa (EMEA) at Boston Scientific. “Only then can we have meaningful conversations between patients, carers and health care professionals, facilitating early recognition and diagnosis to facilitate timely and effective treatment.”
To learn more about resources for people who experience chronic pain, including a pain centre locator to find local specialists, please visit, www.controlyourpain.co.uk/.
About the survey
The survey was commissioned by Boston Scientific and conducted in July 2024 by Censuswide, a research company. It canvassed 3,009 respondents across the UK, Germany, and Italy aged 16+ experiencing chronic pain, defined as continuous and long-term pain lasting for more than 12 weeks1. The 1,000 UK respondents included 613 women, 382 men, four non-binary and one unspecified. Censuswide abide by and employ members of the Market Research Society, which is based on the European Society for Opinion and Market Research (ESOMAR) principles and are members of The British Polling Council.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.eu and connect on LinkedIn and X, formerly Twitter.
CONTACTS:
Uchenna Izundu
Media Relations, UK and Ireland
EMEA.MediaRelations@bsci.com
References:
1 BMJ. Chronic pain syndromes. Summary. Available at: Chronic pain syndromes - Symptoms, diagnosis and treatment | BMJ Best Practice. Accessed August 2024.
2 Fayaz A, et al. Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open. 2016. 20;6(6):e010364.
3 BMJ Effectiveness of physical activity interventions for improving depression, anxiety and distress: an overview of systematic reviews Available at: https://bjsm.bmj.com/content/57/18/1203. Accessed August 2024.